04419nam 2200745 a 450 991096570040332120251116141212.09786612081439978128208143712820814389780309518345030951834297805850209450585020949(CKB)110986584753510(EBL)3378844(SSID)ssj0000113951(PQKBManifestationID)11130079(PQKBTitleCode)TC0000113951(PQKBWorkID)10102230(PQKB)11429082(MiAaPQ)EBC3378844(Au-PeEL)EBL3378844(CaPaEBR)ebr10495441(OCoLC)923284052(Perlego)4736603(BIP)47416102(EXLCZ)9911098658475351019971118d1997 uy 0engurcn|||||||||txtccrBorderline case international tax policy, corporate research and development, and investment /edited by James M. Poterba1st ed.Washington, D.C. National Academy Press19971 online resource (168 p.)U.S. industry, restructuring and renewal"Board on Science, Technology, and Economic Policy, National Research Council."Papers presented at a conference held at the National Academy of Sciences in Washington, D.C., on February 14, 1997.9780309063685 030906368X Includes bibliographical references and index.section 1. International tax policy and technology investments -- section 2. Industry perspectives on the impact of international tax rules -- section 3. Tax reform : prescriptions and prospects.The growing integration of world markets for capital and goods, coupled with the rise of instantaneous worldwide communication, has made identification of corporations as "American," "Dutch," or "Japanese" extremely difficult. Yet tax treatment does depend of where a firm is chartered. And, as Borderline Case documents, there is little doubt that tax rules for firms doing business in several nations--firms that account for more than three-quarters of corporate R&D spending in the United States--have substantial effects on corporate decisionmaking and, ultimately, U.S. competitiveness. This book explores the impact of the U.S. tax code and its incentives on the international activities of U.S.- and foreign-based firms: basic research outlays, expenditures on product and process development, and plant and equipment investment. The authors include industry experts from large multinational firms in technology and pharmaceuticals, academic researchers who have explored the quantitative impact of tax provisions on R&D, and tax policy analysts who have examined international tax rules in the broader context of tax reform. These experts look at how corporate investment and R&D are shaped by specific tax provisions, such as the definition of taxable income, relative tax burdens on domestic and foreign business, taxation of earnings repatriated to the United States, deductibility of expenses of worldwide operations, and U.S. corporate taxes relative to other countries. The volume explores prescriptions and prospects for tax reform and reviews major reform proposals and their implications for the behavior of multinational business.U.S. industry, restructuring and renewal.International business enterprisesTaxationUnited StatesCongressesResearch, IndustrialTaxationUnited StatesCongressesResearch and development tax creditUnited StatesCongressesCapital investmentsUnited StatesCongressesInternational business enterprisesTaxationResearch, IndustrialTaxationResearch and development tax creditCapital investments336.24/3/0973Poterba James M123221National Research Council (U.S.).Board on Science, Technology, and Economic Policy.MiAaPQMiAaPQMiAaPQBOOK9910965700403321Borderline case192058UNINA